| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/27/2004 | DE10252032A1 Preparation of spherical particles, useful e.g. when loaded with biomolecules, in analysis and diagnosis, comprises forming amine-based vesicles that encapsulate nanoparticles, then polymerization |
| 05/27/2004 | DE10147638B4 Leukozyten-Inaktivierungs-Modul (LIM) Leukocyte inactivation module (LIM) |
| 05/27/2004 | CA2512033A1 Shape-retentive hydrogel particle aggregates and their uses |
| 05/27/2004 | CA2506091A1 Agents for the diagnosis and treatment of tumours that expose altered proteins on the cell surface |
| 05/27/2004 | CA2506090A1 Method of obtaining conjugate vaccines and vaccine compositions containing same |
| 05/27/2004 | CA2506080A1 Prodrugs built as multiple self-elimination-release spacers |
| 05/27/2004 | CA2505914A1 Peptide deformylase activated prodrugs |
| 05/27/2004 | CA2504812A1 Thrombin-carrying bioabsorbable synthetic nonwoven fabric |
| 05/27/2004 | CA2504807A1 Dermastick thickened ointment |
| 05/27/2004 | CA2504670A1 Combinatorial libraries of monomer domains |
| 05/27/2004 | CA2504608A1 Controlled release depot formulations |
| 05/27/2004 | CA2504480A1 An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism |
| 05/27/2004 | CA2503630A1 Improved formulations containing substituted imidazole derivatives |
| 05/27/2004 | CA2501932A1 Use of benzimidazole quinolinones for treating cancer |
| 05/26/2004 | EP1422278A1 Pressure-sensitive adhesive sheet for medical use and process for producing the same |
| 05/26/2004 | EP1421989A1 Microcapsule and production method thereof |
| 05/26/2004 | EP1421956A1 Process for stepwise attachment of polyethylene glycol (PEG) to a polypeptide |
| 05/26/2004 | EP1421955A1 Percutaneous absorption preparations |
| 05/26/2004 | EP1421954A1 Materials sustainedly releasing drug in vivo |
| 05/26/2004 | EP1421946A1 A pharmaceutical being used for treating hiv infection, the composition and uses thereof |
| 05/26/2004 | EP1421940A1 Medical composition for external use for dermatosis |
| 05/26/2004 | EP1421939A1 Sustained release preparation of a macrolide compound like tacrolimus |
| 05/26/2004 | EP1421938A1 Antitumor agents and process for producing the same |
| 05/26/2004 | EP1421932A1 Polyacrylic film forming compositions |
| 05/26/2004 | EP1421170A2 Therapeutic delivery compositions and methods of use thereof |
| 05/26/2004 | EP1421120A1 Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander |
| 05/26/2004 | EP1421115A2 Soluble t cell receptor |
| 05/26/2004 | EP1421108A2 Antimicrobial and anti-inflammatory peptides |
| 05/26/2004 | EP1421092A1 Neutral glycosphingolipids and glycosyl-sphingosines and methods for isolating the same |
| 05/26/2004 | EP1420880A2 Stabilization and terminal sterilization of phospholipid formulations |
| 05/26/2004 | EP1420831A1 Lipid constructs as therapeutic and imaging agents |
| 05/26/2004 | EP1420829A2 Immunomodulatory compositions, formulations, and methods for use thereof |
| 05/26/2004 | EP1420828A2 Lipophilic drug compositions |
| 05/26/2004 | EP1420827A1 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 05/26/2004 | EP1420818A1 Antigenic compositions |
| 05/26/2004 | EP1420802A1 Increased solubility flavanolignan preparations |
| 05/26/2004 | EP1420798A2 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 05/26/2004 | EP1420797A1 Dermal therapy using phosphate derivatives of electron transfer agents |
| 05/26/2004 | EP1420792A2 Products and drug delivery vehicles |
| 05/26/2004 | EP1420787A2 Ophthalmic composition comprising an ascomycin |
| 05/26/2004 | EP1420783A1 Stable emulsion composition |
| 05/26/2004 | EP1420777A2 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| 05/26/2004 | EP1420767A1 Compositions containing itraconazole and their preparation methods |
| 05/26/2004 | EP1420765A1 Injection molding process for the preparation of an oral delivery device for a pharmaceutically active agent |
| 05/26/2004 | EP1420762A1 Residual solvant extraction method and microparticles produced thereby |
| 05/26/2004 | EP1420760A2 Aerosolized decongestants for the treatment of sinusitis |
| 05/26/2004 | EP1420759A2 Pharmaceutical compositions for the treatment of asthma |
| 05/26/2004 | EP1420748A2 Peg-modified uricase |
| 05/26/2004 | EP1420743A2 Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function |
| 05/26/2004 | EP1420716A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues |
| 05/26/2004 | EP1420681A2 Peptide-based multimeric targeted contrast agents |
| 05/26/2004 | EP1420645A1 Multivesicular emulsion topical delivery systems |
| 05/26/2004 | EP1420643A2 Enhancement of transfection of dna into the liver |
| 05/26/2004 | EP1299095B1 Clear aqueous anaesthetic composition |
| 05/26/2004 | EP1265612B1 Pharmaceutical composition comprising pemetrexed together with monothioglycerol, l-cystein or thioglycolic acid |
| 05/26/2004 | EP1251827B1 Nasally administrable antifungal cyclic peptide compositions |
| 05/26/2004 | EP1206258B1 Compositions containing esters for treating parasitic infestations of organisms |
| 05/26/2004 | EP1196443B1 Erythropoietin conjugates with polyethylenglycol |
| 05/26/2004 | EP1189857B1 Branched largely insatured fatty alcohols |
| 05/26/2004 | EP1165074B1 Viral treatment |
| 05/26/2004 | EP1161226B1 Phosphocholine linked prodrug derivatives |
| 05/26/2004 | EP1131050B1 Galenic formulations fast disintegrating in the mouth and method for preparing same |
| 05/26/2004 | EP1071398B1 Implants for administering substances and methods of producing implants |
| 05/26/2004 | EP1069885B1 Ophthalmic solution comprising glycogen |
| 05/26/2004 | EP1067910B1 Controlled release composition |
| 05/26/2004 | EP1059941B1 Pharmaceutical compositions and their use |
| 05/26/2004 | EP0971694B1 Drug preparations for treating sexual dysfunction |
| 05/26/2004 | EP0941068B1 Controlled release microspheres |
| 05/26/2004 | EP0863745B1 Thermosensitive biodegradable polymers based on poly(ether-ester) block copolymers |
| 05/26/2004 | EP0778768B1 Formulations and methods for providing prolonged local anesthesia |
| 05/26/2004 | EP0744959B1 Treatment of antibiotic associated diarrhea |
| 05/26/2004 | EP0740650B1 Codrugs as a method of controlled drug delivery |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500095A Polymer conjugates of neublastin and methods of using ssame |
| 05/26/2004 | CN1499977A Compsns. and method of tissue superoxygenation |
| 05/26/2004 | CN1499968A Method of treatment of dopamine-related dysfuction |
| 05/26/2004 | CN1499963A Parasiticidal compsns. and methods of use |
| 05/26/2004 | CN1499962A Adhesive patch |
| 05/26/2004 | CN1499960A Chornotherapeutic dosage forms |
| 05/26/2004 | CN1499959A Pharmaceutical compsn. comprising poorly water-soluble active ingredient, surfactant and water-soluble polymer |
| 05/26/2004 | CN1499958A Medical aerosol formulations |
| 05/26/2004 | CN1499930A Antifungal compsn. with enhanced bioavailability |
| 05/26/2004 | CN1499929A Formulations comprising entrapped active ingredients and uses thereof |
| 05/26/2004 | CN1150969C Liquid thickener for surfactant systems |
| 05/26/2004 | CN1150943C Immobilized activity stabilized LHRH-antagonist complexes, method for prodn. thereof |
| 05/26/2004 | CN1150904C Pharmaceutical compositions for oral administration of molecular iodine |
| 05/26/2004 | CN1150900C Pharmaceutical compositions for oral administration, comprising active substance and cyclodextrin |
| 05/26/2004 | CN1150897C Injectable composition of non-steroidal anti-inflammatory drugs |
| 05/26/2004 | CN1150895C Dry Powder for inhalation |
| 05/26/2004 | CN1150893C Pharmaceutical compsn. having two coating layers |
| 05/26/2004 | CN1150892C Fish gelatinous composition for use as ingredient in tablets |
| 05/26/2004 | CN1150890C Medicinal aerosol formulations |
| 05/26/2004 | CN1150889C Oral Micro-emulsion composition of silybin |
| 05/26/2004 | CN1150888C Peroral active agent suspension |
| 05/26/2004 | CN1150884C Method for eeliminating scabriculous and/or wrinkle and compsn. |
| 05/25/2004 | US6740660 For amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects to mammal |
| 05/25/2004 | US6740639 L-tyrosyl-d-alanyl-glycyl-n-methylphenylalanyl-glycyl -isopropylamide and cyclodextrin derivatives; analgesic, antiinflammatory, nonaddictive properties |
| 05/25/2004 | US6740637 Photodynamic therapy (pdt) photosensitizers; tumor diagnosis; conjugation with cell-specific ligands, target the tumor site; melanocyte stimulating hormones conjugates are suitable for pdt of melanoma tumors |
| 05/25/2004 | US6740634 Biologically active peptide (an lh-rh derivative), hydroxynaphthoic acid (3-hydroxy-2-naphthoic acid) and a biodegradable polymer (lactic acid-glycolic acid copolymer); prostatic cancer or hypertrophy, endometriosis, hysteromyoma |
| 05/25/2004 | US6740525 Adenoviral capsid containing chimeric protein IX |